Mckesson BuPROPion HCL Tablets Recall: Moisture Content Failure
Mckesson Packaging Services recalls BuPROPion HCL 75mg tablets due to moisture content exceeding specifications. Affected lots expire April 2018 or June 2018. No remedy specified in official notice.
Recall notice
Failed Moisture Limits: Product tested out-of-specification for moisture content.
Contact the company
What happened, in plain English
Mckesson Packaging Services is recalling BuPROPion HCL 75mg tablets that failed moisture tests. This could potentially affect product stability and safety, though the recall doesn't specify a remedy. Read more at govinfonow.com/recall/41593-mckesson-bupropion-hcl-tablets-recall-moisture-content-failure.
Source Summary by GovInfoNow · govinfonow.com/recall/41593-mckesson-bupropion-hcl-tablets-recall-moisture-content-failure · Updated October 8, 2026 · FDA enforcement record: FDA #D-0928-2017
Cite this page
“Mckesson BuPROPion HCL Tablets Recall: Moisture Content Failure.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/41593-mckesson-bupropion-hcl-tablets-recall-moisture-content-failure. Based on FDA recall #D-0928-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0928-2017%22&limit=1).
Why it’s dangerous
The tablets tested out of specification for moisture content. This could lead to potential stability issues, though the exact risk to health isn't clearly described in the recall notice.
Who’s affected
Prescription drug users who purchased the specific lots of BuPROPion HCL tablets from the listed manufacturers. People taking this medication for depression or other conditions may be affected.
How to tell if you have this one
Check for the product name 'BuPROPion HCL Tablets, USP, 75 mg' packaged as 100 tablets (10x10). Look for lot numbers 0113148, 0113149, 0113150 (expiring April 2018) or 0113636 (expiring June 2018) or 0114513 (expiring October 2018).
- Brand
Mckesson Packaging Services- Category
Drug
What to do — step by step
Check Product Details
Identify the lot number and expiration date on the packaging to determine if your tablets are affected.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the US” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.7 years after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0928-2017 (May 30, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0928-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.